Obesity as a Risk Factor and Prognostic Indicator for B-cell Lymphoma: An Umbrella Review

• Víctor Juan Vera-Ponce

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

• Fiorella E. Zuzunaga-Montoya

  Universidad Continental, Lima, Perú

• Nataly Mayely Sanchez-Tamay

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

  https://orcid.org/0009-0003-5951-4196

• Lupita Ana Maria Valladolid-Sandoval

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

• Jhosmer Ballena-Caicedo

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

• Juan Carlos Bustamante-Rodríguez

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

• Angie Chuquimbalqui Coronel

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

• Christian Humberto Huaman-Vega

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Instituto de Salud Integral e Intercultural (ISI), Facultad de Ciencias de la Salud, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

  https://orcid.org/0000-0003-2333-2254

• Carmen Inés Gutierrez De Carrillo

  Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú and Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú

  https://orcid.org/0000-0002-4711-7201

Introduction: Obesity constitutes an important risk factor for numerous chronic diseases, including various types of cancer. Epidemiological evidence shows that individuals with elevated body mass index (BMI) present a higher incidence of malignant tumors, including hematological neoplasms like B-cell lymphomas.

Objective: To synthesize and evaluate the available evidence regarding the dual role of obesity both as a risk factor for developing B-cell lymphoma and as a prognostic indicator in patients already diagnosed with this malignancy.

Methodology: This umbrella review followed PRISMA guidelines. A comprehensive search was conducted in PubMed/MEDLINE, Scopus, Embase, Web of Science, and Cochrane databases. Studies were included if they were systematic reviews or meta-analyses examining obesity/BMI as a risk factor or prognostic indicator for B-cell lymphoma, particularly DLBCL. The ROBIS tool was used to assess methodological quality.

Results: Systematic reviews consistently demonstrate that elevated BMI increases the risk of developing DLBCL, with relative risk estimates between 1.11-1.31. Obese individuals have approximately 11-31% greater risk compared to those of normal weight, with stronger associations observed for BMI during early adulthood. For prognosis, while underweight consistently shows negative effects on survival, the impact of overweight and obesity varies. One review identified a protective effect of overweight (BMI 25-29.9 kg/m²) on overall survival (HR=0.86), suggesting an "obesity paradox," while others found neutral effects.

Conclusions: The obesity-lymphoma relationship involves chronic inflammation, adipokine dysregulation, insulin resistance, and altered tumor microenvironment. Clinical recommendations include detailed body composition assessments, personalized nutritional interventions, and adapted physical exercise programs.

Obesity and overweight [Internet]. [citado el 25 de febrero de 2025]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 2016; 22(7 Suppl): s176-185.

IARC identifies eight additional cancer sites linked to overweight and obesity. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit 2016; 22(8): 641.

Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE, Xu W, et al. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries. Cancer Med 2024; 13(5): e7056.

Mwalim MK, Leong E, Ong SK, Mohamad Z. Non-Hodgkin lymphoma incidence, mortality, and survival trends in Brunei Darussalam from 2011 to 2020. BMC Cancer 2024; 24(1): 994.

Larsson SC, Wolk A. Obesity and risk of non-Hodgkin’s lymp-homa: a meta-analysis. Int J Cancer 2007; 121(7): 1564-70.

Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk 2014; 14(2): 122-30.

Vera-Ponce VJ, Loayza-Castro JA, Vásquez-Romero LEM, Zuzunaga-Montoya FE. Body Mass Index as a Risk Factor for Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. Int J Stat Med Res 2024; 13: 124-33.

Wang Z, Zhang J, Yan L, Xu W, Xu Z, Ding X. Effects of body mass index on the prognosis of patients with diffuse large B-cell lymphoma: a Meta-analysis. J Leuk Lymphoma 2021; 419-25.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; n71.

Wang Z, Luo S, Zhao X. The Prognostic Impact of Body Mass Index in Patients with Diffuse Large B-Cell Lymphoma: A Meta-Analysis. Nutr Cancer 2021; 73(11-12): 2336-46.

Hidayat K, Li H-J, Shi B-M. Anthropometric factors and non-Hodgkin’s lymphoma risk: systematic review and meta-analysis of prospective studies. Crit Rev Oncol Hematol 2018; 129: 113-23.

Aleixo GFP, Sheu M, Mirzai S, Majhail NS. Prognostic Impact of Adiposity in Hematological Malignancies: A Systematic Review and Meta-analysis. Clin Lymphoma Myeloma Leuk 2022; 22(10): 726-34.

Divella R, De Luca R, Abbate I, Naglieri E, Daniele A. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 2016; 7(15): 2346-59.

Jiménez-Cortegana C, Hontecillas-Prieto L, García-Domínguez DJ, Zapata F, Palazón-Carrión N, Sánchez-León ML, et al. Obesity and Risk for Lymphoma: Possible Role of Leptin. Int J Mol Sci 2022; 23(24): 15530.

Hosgood HD, Gunter MJ, Murphy N, Rohan TE, Strickler HD. The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma. Front Oncol [Internet] 2018 [citado el 25 de febrero de 2025]; 8.

Corrêa LH, Corrêa R, Farinasso CM, de Sant’Ana Dourado LP, Magalhães KG. Adipocytes and Macrophages Interplay in the Orchestration of Tumor Microenvironment: New Implications in Cancer Progression. Front Immunol [Internet] 2017 [citado el 25 de febrero de 2025]; 8.

Chihara D, Larson MC, Robinson DP, Thompson CA, Maurer MJ, Casulo C, et al. Body mass index and survival of patients with lymphoma. Leuk Lymphoma 2021; 62(11): 2671-8.

• PDF
• Suppl

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.